Inside Drug Pricing

Trump Pegs PBM Reform A Priority, Wyden Pushes Hard For Lame-Duck Reforms

By Gabrielle Wanneh, Sigi Ris / December 9, 2024 at 6:45 PM

Reforming pharmacy benefit manager practices is a drug-pricing priority for incoming President Donald Trump, as well as a top lame-duck health care demand from outgoing Senate Finance Chair Ron Wyden (D-OR).

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

Inside Drug Pricing

Trump Pegs PBM Reform A Priority, Wyden Pushes Hard For Lame-Duck Reforms

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.